Journal article Open Access
Dean, Michael; Carrington, Mary; Winkler, Cheryl; Huttley, Gavin A.; Smith, Michael W.; Allikmets, Rando; Goedert, James J.; Buchbinder, Susan P.; Vittinghoff, Eric; Gomperts, Edward; Donfield, Sharyne; Vlahov, David; Kaslow, Richard A.; Saah, A. J.; Rinaldo, Charles; Detels, Roger; Multicenter Aids Cohort Study,; Study, Hemophilia Growth and Development; Multicenter Hemophilia Cohort Study,; Study, Multicenter Aids Cohort; San Francisco City Cohort,; Study, Multicenter Hemophilia Cohort; Alive Study,; Cohort, San Francisco City; O'Brien, Stephen J.
The chemokine receptor 5 (CKR5) protein serves as a secondary receptor on CD4+ T lymphocytes for certain strains of human immunodeficiency virus-type 1 (HIV-1). The CKR5 structural gene was mapped to human chromosome 3p21, and a 32-base pair deletion allele (CKR5Δ32) was identified that is present at a frequency of ~0.10 in the Caucasian population of the United States. An examination of 1955 patients included among six well-characterized acquired immunodeficiency syndrome (AIDS) cohort studies revealed that 17 deletion homozygotes occurred exclusively among 612 exposed HIV-1 antibody-negative individuals (2.8 percent) and not at all in 1343 HlV-1-infected individuals. The frequency of CKR5 deletion heterozygotes was significantly elevated in groups of individuals that had survived HIV-1 infection for more than 10 years, and, in some risk groups, twice as frequent as their occurrence in rapid progressors to AIDS. Survival analysis clearly shows that disease progression is slower in CKR5 deletion heterozygotes than in individuals homozygous for the normal CKR5 gene. The CKR5Δ32 deletion may act as a recessive restriction gene against HIV-1 infection and may exert a dominant phenotype of delaying progression to AIDS among infected individuals.